New Zealand markets closed

ICPT Jan 2023 22.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.63000.0000 (0.00%)
At close: 12:11PM EDT
Full screen
Previous close1.6300
Open1.6100
Bid0.6000
Ask0.9500
Strike22.50
Expiry date2023-01-20
Day's range1.6000 - 1.7000
Contract rangeN/A
Volume612
Open interest1.22k
  • Motley Fool

    Nike's Down, but These 2 Nasdaq Stocks Fell Even Further Friday

    Futures on the Nasdaq Composite (NASDAQINDEX: ^IXIC) were all over the map in premarket trading Friday morning, as many investors reacted negatively to bad news from athletic footwear and apparel giant Nike in its most recent quarterly financial report. Nike's premarket losses of 13% were extreme, but it turns out that there were two Nasdaq stocks with even bigger declines early Friday. Both Intercept Pharmaceuticals (NASDAQ: ICPT) and Rent-A-Center (NASDAQ: RCII) posted steeper drops as they tried to work through some major setbacks and reassure their shareholders that the future could improve.

  • GlobeNewswire

    Intercept Pharmaceuticals Announces REVERSE Phase 3 Study of Obeticholic Acid (OCA) in Compensated Cirrhosis due to NASH Did Not Meet its Primary Endpoint

    Company remains on track to resubmit new drug application (NDA) for OCA in its lead indication of fibrosis due to NASH by year end based on its positive Phase 3 REGENERATE studyMORRISTOWN, N.J., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that REVERSE, a Phase 3 study evaluating the safety and effi

  • Zacks

    Intercept (ICPT) Stock Gains 13% in 3 Months: Here's Why

    Intercept (ICPT) gains 13% in the past three months on positive regulatory and pipeline updates.